Empagliflozin improves chronic hypercortisolism-induced abnormal myocardial structure and cardiac function in mice

• Main Authors: Qing-Qing Zhang (Author), Guo-Qing Li (Author), Yi Zhong (Author), Jie Wang (Author), An-Ning Wang (Author), Xiao Zhou (Author), Xiao-Ming Mao (Author)
• Format: Book
• Published: SAGE Publishing, 2020-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Chronic exposure to excess glucocorticoids is frequently associated with a specific cardiomyopathy. Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has beneficial effects as it aids in the reduction of heart failure and cardiovascular mortality in hospitalized patients...